Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paus

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Clinical Chemistry|October 1, 1993
Homogeneous immunofluorometric assays of alpha-fetoprotein with macroporous, monosized particles and flow cytometryJ Frengen, R Schmid, B Kierulf, et al.
British Journal of Cancer|January 1, 1997
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II studyE H Hernes, S D Fosså, S Vaage, et al.
The Journal of Urology|April 29, 1998
Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasiaE Paus, O Nilsson, O P Børmer, et al.
Biopharmaceutics & Drug Disposition|October 1, 1996
Pharmacokinetics of reboxetine in healthy volunteers. Single against repeated oral doses and lack of enzymatic alterationsC Pellizzoni, I Poggesi, N P Jørgensen, et al.
British Journal of Urology|January 1, 1995
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinomaA Berner, H Waere, J M Nesland, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 2, 2007
Alpha fetoprotein is increasing with age in ataxia-telangiectasiaA Stray-Pedersen, A L Borresen-Dale, E Paus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1990
Prognosis in patients with metastatic non-seminomatous testicular cancerN Aass, S D Fosså, S Ous, et al.
British Journal of Urology|April 1, 1990
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?N Aass, S D Fosså, S Ous, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptideE Bork, M Hansen, P Urdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA)O Klepp, P Flodgren, H Maartman-Moe, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Clinical Chemistry|October 1, 1993
Homogeneous immunofluorometric assays of alpha-fetoprotein with macroporous, monosized particles and flow cytometryJ Frengen, R Schmid, B Kierulf, et al.
British Journal of Cancer|January 1, 1997
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II studyE H Hernes, S D Fosså, S Vaage, et al.
The Journal of Urology|April 29, 1998
Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasiaE Paus, O Nilsson, O P Børmer, et al.
Biopharmaceutics & Drug Disposition|October 1, 1996
Pharmacokinetics of reboxetine in healthy volunteers. Single against repeated oral doses and lack of enzymatic alterationsC Pellizzoni, I Poggesi, N P Jørgensen, et al.
British Journal of Urology|January 1, 1995
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinomaA Berner, H Waere, J M Nesland, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 2, 2007
Alpha fetoprotein is increasing with age in ataxia-telangiectasiaA Stray-Pedersen, A L Borresen-Dale, E Paus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1990
Prognosis in patients with metastatic non-seminomatous testicular cancerN Aass, S D Fosså, S Ous, et al.
British Journal of Urology|April 1, 1990
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?N Aass, S D Fosså, S Ous, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptideE Bork, M Hansen, P Urdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA)O Klepp, P Flodgren, H Maartman-Moe, et al.
Pageof 7